• SELECT SITE CURRENCY
Select a currency for use throughout the site
Clariant: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market
Venture Planning Group (VPG), October 2010, Pages: 41
A strategic assessment of Clariant, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.Contains 41 pages and 5 tables
SECTION I. EXECUTIVE SUMMARY
- A 3-5 page synopsis of main sections.
SECTION II. BUSINESS ORGANIZATION
- History of the life science intermediates business evolution, important to the understanding of the corporate culture, management mentality and strategies.
- Recent acquisitions, divestitures and significant organizational changes.
- Current organizational structure.
SECTION III. SENIOR MANAGEMENT
- Background of key executives.
SECTION IV. FACILITIES AND EMPLOYEES
- Major administrative, manufacturing and R&D facilities in the U.S. and abroad.
- New plants under construction.
- U.S. and international work force size and distribution.
SECTION V.TECHNOLOGICAL KNOW-HOW
- Internally developed and acquired technologies, and related capabilities.
- Proprietary technologies and patent litigations.
SECTION VI. PRODUCT PORTFOLIO
- Extensive review of major product lines.
SECTION VII. MARKETING TACTICS
- Major promotional strategies.
- Distribution approaches.
- Product service and support.
SECTION VIII. FINANCIAL ANALYSIS
- Sales and operating profit by division, product line, geographic region and country.
- Five-year sales and profit performance.
SECTION IX. R&D EXPENDITURES AND MAJOR PROGRAMS
- Estimated R&D budget.
- Research facilities and staff.
- New technologies, products and applications in development.
SECTION X. COLLABORATIVE ARRANGEMENTS
- Major joint venture, distribution, OEM and licensing partners, both industrial and academic.
- Terms of collaborative agreements and specific products involved.
SECTION XI. STRATEGIC DIRECTION
- Specific business, new product development and marketing strategies.
- Strengths and weaknesses.
- Anticipated acquisitions, joint ventures and divestitures
List of Tables:
-CLARIANT SALES BY DIVISION
- CLARIANT SALES GROWTH BY DIVISION
- CLARIANT PROFIT BY DIVISION
- CLARIANT PROFIT GROWTH BY DIVISION
- CLARIANT SALES BY GEOGRAPHIC REGION